Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures
- PMID: 16302009
- DOI: 10.1038/sj.mp.4001775
Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures
Abstract
The gene coding for ubiquilin 1 (UBQLN1) is located near a linkage peak on chromosome 9q22.2 and it also impacts the function of presenilin proteins involved in early-onset Alzheimer's disease (AD). Recently, genetic variation in UBQLN1 has been shown to affect the risk of AD in two independent family-based samples. The purpose of this study was to confirm the reported association in a large case-control sample and to also examine the association of UBQLN1 SNPs with quantitative measures of AD progression, namely age-at-onset (AAO), disease duration and Mini-Mental State Examination (MMSE) score. We examined the associations of three SNPs in the UBQLN1 gene (intron 6/A>C, intron 8/T>C and intron 9/A>G) in up to 978 LOAD cases and 808 controls. All SNPs were in significant linkage disequilibrium (P<0.0001). While modest significant associations were observed in the single-site regression analysis, 3-site haplotype analysis revealed significant associations (P<0.0001 for overall haplotype analysis). One common haplotype (H4) defined by intron 6/A-intron 8/C-intron 9/G alleles was associated with AD risk and one less common haplotype (H5) defined by intron 6/C-intron 8/C-intron 9/A alleles was associated with protection. The adjusted odds ratios with potentially one and two copies of risk haplotype H4 were 1.5 (95% CI: 0.99-2.26; P=0.054) and 3.66 (95% CI: 1.43-9.39; P=0.007), respectively, and odds ratio for haplotype H5 carriers was 0.31 (95% CI: 0.10-0.95; P=0.0398). In addition to disease risk, the homozygosity of the risk haplotype was also associated with older AAO, longer disease duration and lower MMSE score. In summary, our data from a large case-control cohort indicate that genetic variation in the UBQLN1 gene has a modest effect on risk, AAO and disease duration of AD. Our haplotype data suggest the presence of additional putative functional variants either in the UBQLN1 gene or nearby genes and provide strong justification for additional work in this region on chromosome 9.
Similar articles
-
Analysis of UBQLN1 variants in a Polish Alzheimer's disease patient: control series.Dement Geriatr Cogn Disord. 2008;25(4):366-71. doi: 10.1159/000121006. Epub 2008 Mar 14. Dement Geriatr Cogn Disord. 2008. PMID: 18340109
-
The UBQLN1 polymorphism, UBQ-8i, at 9q22 is not associated with Alzheimer's disease with onset before 70 years.Neurosci Lett. 2006 Jan 9;392(1-2):72-4. doi: 10.1016/j.neulet.2005.08.064. Epub 2005 Oct 6. Neurosci Lett. 2006. PMID: 16214290
-
Relationship of the Ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function.Neurosci Lett. 2007 Aug 31;424(1):1-5. doi: 10.1016/j.neulet.2007.07.015. Epub 2007 Aug 1. Neurosci Lett. 2007. PMID: 17709205
-
Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease.Am J Epidemiol. 2005 Aug 15;162(4):305-17. doi: 10.1093/aje/kwi202. Epub 2005 Jul 20. Am J Epidemiol. 2005. PMID: 16033878 Review.
-
Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study.Exp Gerontol. 2006 Jan;41(1):85-92. doi: 10.1016/j.exger.2005.10.005. Epub 2005 Nov 16. Exp Gerontol. 2006. PMID: 16297587 Review.
Cited by
-
Effects of ubiquilin 1 on the unfolded protein response.J Mol Neurosci. 2009 May;38(1):19-30. doi: 10.1007/s12031-008-9155-6. Epub 2008 Oct 25. J Mol Neurosci. 2009. PMID: 18953672
-
APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.Annu Rev Clin Psychol. 2009;5:343-62. doi: 10.1146/annurev.clinpsy.032408.153625. Annu Rev Clin Psychol. 2009. PMID: 19327032 Free PMC article. Review.
-
Meta-analysis of Ubiquilin1 gene polymorphism and Alzheimer's disease risk.Med Sci Monit. 2014 Nov 12;20:2250-5. doi: 10.12659/MSM.891030. Med Sci Monit. 2014. PMID: 25387430 Free PMC article.
-
Aggresome formation and neurodegenerative diseases: therapeutic implications.Curr Med Chem. 2008;15(1):47-60. doi: 10.2174/092986708783330692. Curr Med Chem. 2008. PMID: 18220762 Free PMC article. Review.
-
Remodeling without destruction: non-proteolytic ubiquitin chains in neural function and brain disorders.Mol Psychiatry. 2021 Jan;26(1):247-264. doi: 10.1038/s41380-020-0849-7. Epub 2020 Jul 24. Mol Psychiatry. 2021. PMID: 32709994 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
